Brookline Capital Markets Starts POINT Biopharma Global Inc. (PNT) at Buy

December 1, 2021 3:23 AM EST Send to a Friend
Brookline Capital Markets analyst Kemp Dolliver initiates coverage on POINT Biopharma Global Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login